Suministro principio activo ALPROLIX (Factor IX)
Buyer
NameDirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
CountryES
Published2026-05-27
Deadline—
Value
Estimated—
Awarded€403,705 · 403,705.3 EUR
WinnerSWEDISH ORPHAN BIOVITRUM S.L
Who already wins at this buyer
Firms with recorded awards from Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| IPSEN PHARMA, S.A.U. | 1 | €595,637 | 2026-06-18 |
| IPSEN PHARMA, S.A. | 1 | €396,028 | 2026-05-11 |
| MERCK SHARP & DOHME ESPAÑA, S.A. | 1 | €332,277 | 2026-05-11 |
| ROCHE FARMA, S.A. | 1 | €305,648 | 2026-07-13 |
| PFIZER, S.L. | 1 | €249,425 | 2026-06-09 |
CPV codes
33690000 Medical equipment & pharmaceuticalsDescription
El objeto del contrato viene determinado por el suministro de los principios activos denominados "ALPROLIX (FACTOR IX) 1.000 UIVIAL IV" , "ALPROLIX (FACTOR IX) 2.000 UI VIAL IV" y "ALPROLIX (FACTOR IX) 3.000 UI VIAL" para el Hospital Universitario de GranCanaria Dr. Negrín.Dicho objeto corresponde al código 33690000-3 (Medicamentos diversos), de la nomenclatura Vocabulario Común de Contratos (CPV) dela Comisión Europea
Similar tenders
Closest by meaning — across languages, via embeddings.